Results 21 to 30 of about 10,714,680 (266)

Prognostic Value of Lymph Node Density in Patients With T3 and T4 Pyriform Sinus Carcinoma

Technology in Cancer Research & Treatment, 2020
Background/Aim: Lymph node density is a parameter used to more accurately predict tumor recurrence and patient survival. However, its association with surgical outcome in pyriform sinus carcinoma remains unclear.
Lifeng Jia PhD, Jingya Li MS, Ziyuan Zhou PhD, Wei Yuan PhD   +3 more
doaj   +1 more source

Disease-free survival and overall survival of cervical cancer patients after radical hysterectomy and pelvic lymph-node dissection [PDF]

, 2020
Introduction: Radical Hysterectomy and Pelvic Lymph-Node Dissection (RH-PLND), with or without Neoadjuvant Chemotherapy (NAC) nor Adjuvant Therapy (AT), is still the treatment of choice in stages IB-IIB of cervical cancer due to limited access to ...
Ardi Eko Marsanto, -, Brahmana Askandar, -, Primandono Perbowo, -   +2 more
core   +1 more source

Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study

Cancer Medicine, 2020
Background and Aims The prognosis of intrahepatic cholangiocarcinoma (ICC) after radical resection is far from satisfactory; however, the clinical value of adjuvant therapy (AT) remains controversial. This multicenter study aimed to evaluate the clinical
Lei Wang, Manjun Deng, Qiao Ke, Jianying Lou, Shuguo Zheng, Xinyu Bi, Jianming Wang, Wei Guo, Fuyu Li, Jian Wang, Yamin Zheng, Jingdong Li, Shi Cheng, Weiping Zhou, Yongyi Zeng   +14 more
doaj   +1 more source

Comprehensive Analysis of the Expression Characteristics of the Enhancer of the Zeste Homolog 2 Gene in Pan-Cancer

Frontiers in Genetics, 2021
Although more and more studies have shown that EZH2 was closely related to human cancer, no pan-cancer analysis is available. Therefore, we summarized and analyzed the potential carcinogenic effect of EZH2 for the first time based on TCGA (cancer genome ...
Yuanyuan Kang, Ying Zhang, Yan Sun
doaj   +1 more source

Multivariate Cox Survival Analysis - Disease-free survival.

, 2013
Multivariate Cox Survival Analysis - Disease-free survival.
Hans-Juergen Holzhausen (303448), Joerg Weimer (303436), Beyhan Ataseven (303437), Keyur Mehta (303432), Norbert Arnold (112045), Sigrid Hamann (303435), Antonia Sophie Wenners (303431), Berit Mueller (303434), Silvia Darb-Esfahani (110661), Gunther von Minckwitz (303451), Maret Bauer (303454), Christian Schem (303438), Carsten Denkert (11194), Hyerim Park (303433), Sibylle Loibl (11099), Christoph Thomssen (303445), Walter Jonat (157379), Christoph Mundhenke (303439), Fariba Khandan (303442)   +18 more
core   +1 more source

Disease-Free Survival.

, 2014
Disease-Free Survival.
Stanley L. Liauw (507756), Gene-Fu F. Liu (507754), Eric Bair (55923), Ryan J. Bair (507755), Matthew Koshy (460252)   +4 more
core   +1 more source

Kaplain-Meier cumulative survival curves for (A) overall survival, (B) disease-free survival, and (C) distant metastasis-free survival.

, 2013
Kaplain-Meier cumulative survival curves for (A) overall survival, (B) disease-free survival, and (C) distant metastasis-free survival.
Jia-Yuan Sun (406033), Zhen-Yu He (406032), Qin Lin (406035), Xun-Xing Guan (406036), San-Gang Wu (406031), Qun Li (222962), Feng-Yan Li (406034), Huan-Xin Lin (131044)   +7 more
core   +1 more source

Kaplan-Meier estimates of disease-free survival (A), relapse-free survival (B), and overall survival (C).

, 2015
Kaplan-Meier estimates of disease-free survival (A), relapse-free survival (B), and overall survival (C).
Hideki Takemura (691534), Yuichiro Higaki (691540), Shigemichi Iwae (691541), Takahide Taguchi (691536), Satoshi Teramukai (386488), Masanori Fukushima (457544), Yasuhisa Hasegawa (691533), Yutaka Hanamure (691543), Tomonori Terada (691535), Takeshi Beppu (691542), Kiyoaki Tsukahara (691531), Kunitoshi Yoshino (691539), Kunihiko Nagahara (691537), Kazuyoshi Kawabata (691546), Masato Fujii (691547), Akira Kubota (691532), Naoyuki Kohno (691545), Kichinobu Tomita (691544), Hiroaki Nakatani (691538)   +18 more
core   +1 more source

Disease-free survival curves for patients with mutations.

, 2016
(A) TP53 and (B) MYD88 genes After applying multiple comparison by using FDR, TP53 and MYD88 showed a tendency for shorter disease-free survival (P = 0.054, both).
JooRyung Huh (3396479), Dong Soon Lee (710952), Sunghoon Huh (3396473), Duhee Bang (736906), Byungjin Hwang (736897), Sungbin Choi (3396470), Si Nae Park (3396488), Kyongok Im (3396467), Jung-Ah Kim (3396485), Hye Yoon Chung (3396482), Eul-Ju Seo (3396476), Je-Hwan Lee (397543)   +11 more
core   +1 more source

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine, Hallie Coltin, Sylvia Cheng, Lucie Lafay‐Cousin, Vanan Issai Magimairajan, Craig Erker, Stéphanie Vairy, Lynette Bowes, Adam Fleming, Donna Johnston, Sarah McKillop, Roona Sinha, Julie Bennett, Christina Coleman, Laura Wheaton, Shayna Zelcer, Samuele Renzi, Thai Hoa Tran   +17 more
wiley   +1 more source